BravoVax is a China-based biotechnology company specializing in developing vaccines such as the multivalent rotavirus vaccine and pneumococcal conjugate vaccine. It has five technology platforms to conduct its research which include bacterial fermentation, cell and virus culture, purification, formulation and quality control and are equipped with advanced instruments (such as fluorescent quantitative polymerase chain reaction).
In 2020, the company partnered with GeoVax, an American biotechnology company, to collaborate on the development of a COVID-19 vaccine. The company's role in the partnership included further development of the vaccine developed by its partner, including testing and manufacturing, as well as directing interactions with Chinese health authorities.
GeoVax, BravoVax to develop vaccine for coronavirus
January 30, 2020
The Biologics News and Reports Portal
January 27, 2020
Documentaries, videos and podcasts
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.